ArticleWorld journal of gastroenterology2025

Targeting the NAD+/SIRT1 axis: A metabolic strategy to overcome oxaliplatin resistance in colorectal cancer.

Md Sadique Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.